High ROE and High ROCE stock: This small-cap company receives orders from Brihanmumbai Municipal Corporation!

In the financial year 2022-2023, the company reduced its debt to Rs 62.61 crore. 

Krsnaa Diagnostics Ltd informed that it has received an order to provide services of lab investigation facilities under "Hinduhridaysamrat Balasaheb Thackeray Chikitsa" for Brihanmumbai Municipal Corporation (BMC) Dispensaries and Hospitals in Mumbai, Maharashtra on Public Private Partnership (PPP) basis.   

Also with the above order, Brihanmumbai Municipal Corporation, Mumbai, Maharashtra has directed us to set up additional 47 Hinduhridaysamrat Balasaheb Thackeray Clinics to provide manpower and logistics facilities for blood collection. The company will set up approx. 600 collection centres across Mumbai city and will carry out 139 routines as well as special pathology tests.   

Today, shares of Krsnaa Diagnostics surged 2.18 per cent to Rs 504.20 in the pre-opening session. At 9:15 am, shares of the company were trading at Rs 513.05 per share with an intraday high of Rs 517.45 and an intraday low of Rs 509.95.    

Krsnaa Diagnostics Ltd offers a wide range of diagnostic services which are enabled by technology, including clinical laboratory services, imaging and teleradiology services. Krsnaa Diagnostics Ltd has an extensive network, which covers both non-metro and lower-tier areas.  

Talking about the financials, this BSE Small-Cap company has a market cap of 1,611 crore. In its Quarterly Results (Q3) and annual results (FY22), the company reported positive numbers. In the financial year 2022-2023, the company reduced its debt to Rs 62.61 crore.  The stock has an ROE of 21 per cent and a ROCE of 18.15.   

Investors should keep this healthcare service provider company’s stock under the radar.